The global Hydroxyprogesterone Caproate Injection market was valued at US$ 270.6 million in 2022 and is projected to reach US$ 341.3 million by 2029, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
Hydroxyprogesterone Caproate Injection Market aims to provide a comprehensive presentation of the global market for Hydroxyprogesterone Caproate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxyprogesterone Caproate Injection. Hydroxyprogesterone Caproate Injection Market contains market size and forecasts of Hydroxyprogesterone Caproate Injection in global, including the following market information:
Global Hydroxyprogesterone Caproate Injection Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Hydroxyprogesterone Caproate Injection Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Hydroxyprogesterone Caproate Injection companies in 2022 (%)
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
We surveyed the Hydroxyprogesterone Caproate Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hydroxyprogesterone Caproate Injection Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Hydroxyprogesterone Caproate Injection Market Segment Percentages, by Type, 2022 (%)
Global Hydroxyprogesterone Caproate Injection Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Hydroxyprogesterone Caproate Injection Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Clinics
- Recovery Center
Global Hydroxyprogesterone Caproate Injection Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Hydroxyprogesterone Caproate Injection Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hydroxyprogesterone Caproate Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Hydroxyprogesterone Caproate Injection revenues share in global market, 2022 (%)
- Key companies Hydroxyprogesterone Caproate Injection sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Hydroxyprogesterone Caproate Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AMAG
- Prasco
- American Regent
- AuroMedics
- Mylan
- Slayback Pharma
- Zydus
- PRM Life Science
- ANI Pharmaceuticals
- SG pharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hydroxyprogesterone Caproate Injection, market overview.
Chapter 2: Global Hydroxyprogesterone Caproate Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Hydroxyprogesterone Caproate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hydroxyprogesterone Caproate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hydroxyprogesterone Caproate Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Industry Market Size
